| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.51T | 12.43T | 10.89T | 8.43T | 5.25T | 5.33T |
| Gross Profit | 7.20T | 7.03T | 5.38T | 5.38T | 4.37T | 4.04T |
| EBITDA | 2.64T | 2.97T | 2.41T | 1.90T | 1.85T | 1.40T |
| Net Income | 1.93T | 1.86T | 1.49T | 1.12T | 1.13T | 777.02B |
Balance Sheet | ||||||
| Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Cash, Cash Equivalents and Short-Term Investments | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Total Debt | 75.71T | 89.40T | 61.23T | 62.41T | 46.73T | 18.09T |
| Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Stockholders Equity | 21.38T | 20.52T | 19.59T | 17.23T | 17.02T | 16.80T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -450.29B | -10.31T | 13.03T | 9.46T | 34.51T |
| Operating Cash Flow | 0.00 | 6.42B | -9.84T | 13.43T | 9.84T | 34.90T |
| Investing Cash Flow | 0.00 | -186.95B | 3.99T | -10.68T | -2.20T | -10.14T |
| Financing Cash Flow | 0.00 | -861.12B | 8.31B | -977.14B | -1.08T | -436.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $120.75B | 2.09 | 9.58% | 2.54% | -0.66% | 23.90% | |
72 Outperform | $159.78B | 10.97 | 13.89% | 1.85% | -15.34% | 16.71% | |
71 Outperform | $275.06B | 12.28 | 11.88% | 4.14% | -9.54% | -22.46% | |
69 Neutral | $183.50B | 13.57 | 9.31% | 2.48% | -1.09% | 8.53% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | $236.98B | 13.89 | 11.78% | 1.80% | -4.37% | 26.41% | |
58 Neutral | $187.65B | 14.89 | 6.71% | 1.94% | -0.62% | 105.57% |